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Classic tissue recombination and in vitro lineage tracing studies suggest that condensed metanephric mesenchyme (MM) gives rise to
nephronic epithelium of the adult kidney. However, these studies do not distinguish between cap mesenchyme and pre-tubular aggregates
comprising the condensed MM, nor do they establish whether these cells have self-renewing capacity. To address these questions, we generated
Cited1-CreERT2 BAC transgenic mice, which express tamoxifen-regulated Cre recombinase exclusively in the cap mesenchyme. Fate mapping
was performed by crossing these mice with the Rosa26RLacZ reporter line and evaluating the location and cellular characteristics of LacZ positive
cells at different time points following tamoxifen injection. These studies confirmed expected results from previous in vitro analysis of MM cell
fate, and provide in vivo evidence that the cap mesenchyme does not contribute to collecting duct epithelium in the adult. Furthermore, by
exploiting the temporally regulated Cre recombinase, these studies show that nephronic epithelium arising at different stages of nephrogenesis has
distinct spatial distribution in the adult kidney, and demonstrate for the first time that the cap mesenchyme includes a population of self-renewing
epithelial progenitor cells.
© 2007 Elsevier Inc. All rights reserved.Keywords: Cap mesenchyme; Metanephric mesenchyme; Kidney development; Lineage tracing; Cited1 BAC transgenic miceIntroduction
The process by which the mammalian kidney develops has
been the subject of extensive investigation over the past five
decades and these studies have elucidated many of the physical
and molecular interactions required for proper nephrogenesis
(for recent reviews see; Boyle and de Caestecker, 2006; Dressler,
2006; Kopan et al., 2007). However, the precise developmental⁎ Corresponding author. Department of Medicine, Vanderbilt University
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doi:10.1016/j.ydbio.2007.10.014origins of the 19 different specialized epithelia comprising the
adult nephron, collecting duct epithelium, renal vasculature and
interstitium of the adult kidney have yet to be established in vivo.
Development of the mammalian kidney is dependent on
reciprocal tissue interaction between the ureteric bud (UB) and
the metanephric mesenchyme (MM). Beginning at embryonic
day 10.5 (E10.5) in mice the UB emerges from the nephric duct
and invades the overlying MM. This process is marked by the
patterning of the MM into peripheral, loosely associated stroma,
and more condensed elements surrounding the UB tip. The
sequence of MM invasion and patterning occurs in an iterative
fashion throughout nephrogenesis as the UB branches repeat-
edly with each tip becoming the induction site of successive
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ing UB tips is patterned into two morphologically and
molecularly distinct zones: cap mesenchyme, an organized
layer of cells opposed to the dorsal and lateral surfaces of UB
tips, and pre-tubular aggregates, which are contiguous with the
ventral and lateral aspect of the cap mesenchyme and are
committed to differentiate into nephronic epithelium (Sariola,
2002). This distinction between cap mesenchyme and pre-
tubular aggregates is important as it is likely that only a
proportion of cells within the cap mesenchyme develop into pre-
tubular aggregates. This suggests the cap mesenchymemay give
rise to other cell types within the adult and/or embryonic kidney,
which could include contribution to collecting duct epithelium,
endothelium and/or stromal mesenchyme. Furthermore, this
raises the possibility that a proportion of cap mesenchyme cells
are committed at an early stage to self-renew and repopulate this
progenitor pool over the course of nephrogenesis.
Classic tissue recombination experiments have led to the
general understanding that nephronic epithelial structures
(including proximal and distal tubular as well as glomerular
epithelial elements) are derived from the MM, while the
collecting system arises from the UB, which does not contribute
to nephronic epithelium (Aubach, 1958; Saxen, 1987). These
observations are supported by in vitro lineage tracing studies
demonstrating that theMM can give rise to nephronic epithelium
(Herzlinger et al., 1992; Qiao et al., 1995). However, the
inability to differentially label subpopulations of cells within the
MM limits the ability of these techniques to determine the fate of
cap mesenchyme vs. pre-tubular aggregates and stromal
mesenchyme. Furthermore, these in vitro studies are limited in
their capacity to track the fate of MM cells at different stages of
nephrogenesis, and to determine the spatial and temporal origins
of more complex epithelial structures that form at later stages of
kidney development. Questions have also been raised by in vitro
lineage tracing studies suggesting that the MM may in fact give
rise to collecting duct epithelial cells (Qiao et al., 1995).
More recently, in vivo analysis of cell fate during development
has been facilitated by the creation of Cre-dependent conditional
reporter lines to track the fate of cell populations expressing Cre
under the control of tissue-specific promoters. Two previous
reports briefly address the fate of MM cells in the developing
kidney using Pax3-Cre (Grieshammer et al., 2005) and
Rar2b-Cre (Kobayashi et al., 2005). Crossing these mice with
the Rosa26RLacZ (R26RLacZ) conditional reporter line demon-
strates that the MM gives rise to nephronic epithelium in vivo.
However, as Pax3-Cre and Rar2b-Cre are expressed throughout
the MM from the earliest stages of metanephric kidney
development, these studies do not distinguish between the fates
of different cellular compartments within the MM, nor can they
address patterns of MM differentiation at different stages of
development. In addition, as these lines express active Cre in the
MM throughout nephrogenesis, they cannot address questions
regarding the capacity of the MM to undergo self-renewal.
Recent studies have identified two distinct transcriptional
regulators that are uniquely expressed in the cap mesenchyme,
Cited1 and Six2 (Boyle et al., 2007; Self et al., 2006). Six2
mRNA is expressed throughout the cap mesenchyme surround-ing the UB tips and branch points (Self et al., 2006), while
Cited1 protein (and mRNA) expression is restricted to the more
lateral compartment of the cap mesenchyme, and unlike Six2 is
absent from the UB branch point cleft (Boyle et al., 2007).
Neither Six2 nor Cited1 are expressed in pre-tubular aggregates
or stromal mesenchyme of the embryonic kidney. We therefore
saw the expression domain of Cited1 as a unique opportunity
to track the fate of a distinct group of cells within the MM over
the course of nephrogenesis. Here, we describe the generation
and characterization of Cited1-CreERT2 transgenic mice,
which express tamoxifen-activated (and therefore temporally
regulated) Cre recombinase in the cap mesenchyme. By
crossing these animals with the R26RLacZ reporter line and
activating Cre, we have created the first detailed fate map of
cap mesenchyme cells over the course of metanephric kidney
development.
Materials and methods
Generation of BAC transgene and transgenic animals
TheCited1-CreERT2 BAC transgenewas created as previously described (Lee
et al., 2001). Briefly, a BAC (RP23-204G22,mouse 129/SvJ; Invitrogen) covering
the entire Cited1 locus as well as 190 kb of 5′ and 30 kb of 3′ genomic sequence
was electroporated into the EL250 Escherichia coli strain, which carries a
temperature sensitiveλ phage Red recombination system and arabinose inducible
Flp recombinase. A targeting vector containing a CreERT2-IRESeGFP-frt TETR
frt cassette flanked by 500 bp homology arms corresponding to theCited1 locus at
the transcriptional start site (Fig. 1A) was electroporated into EL250 cells
containing the Cited1 BAC and induced to undergo homologous recombination
by 42 °C heat shock. Homology arms were generated using PCR and designed to
remove the Cited1 transcriptional start site and the subsequent 12 bp within the
BAC, but do not delete any additional coding sequence to avoid removal of
possible intronic regulatory elements within the Cited1 locus (Fig. 1A).
Dual chloramphenicol/tetracycline resistant clones that carried the Cited1
BAC with the predicted insertion were treated with arabinose to activate
inducible Flp recombinase, thereby removing the TetR cassette. To remove the
flanking LoxP sites in the pBACe3.6 vector backbone which, if present, could
result in loss of the transgene upon activation of Cre, two additional
modifications of the Cited1 BAC were made sequentially in vitro using
homologous recombination. The LoxP511 site was replaced with a kanamycin
resistance cassette flanked by 50 bp homology arms complementary to the
sequence adjacent to the LoxP511 site (pLoxP511OUTKan). Subsequently, the
LoxP site in the pBACe3.6 vector backbone was replaced with a zeocin
resistance cassette flanked by 500 bp homology arms complementary to the
sequence adjacent to the LoxP site (pLoxPOUTZeo). The details of the
pLoxP511OUTKan and pLoxPOUTZeo vectors are available upon request
(KKD and EMSS, unpublished data). After targeting procedures were
completed, removal of LoxP sites was confirmed by PCR and sequencing
across the deleted region with flanking primers. These modifications conferred
Kan and Zeo resistance to the Cited1-CreERT2 BAC.
For generation of transgenic animals, Cited1-CreERT2-IRESeGFP BAC
DNAwas prepared using standard cesium chloride purification and dialyzed into
TE pH 7.4 for microinjection using Centriprep-30 columns (Micron 4306) as
described (DiLeone et al., 1998, 2000). Dilutions of purified BAC DNA were
cut with Not I and subjected to pulse-field gel electrophoresis against a standard
to estimate concentration. Circular BAC DNA was diluted to 1 ng/μl for
pronuclear injection of zygotes derived from FVB mice and injected zygotes
were implanted into pseudo-pregnant ICR females.
Mouse lines and tamoxifen injection
Transgenic mice generated using Cited1-CreERT2-IRESeGFP BAC DNA
are hereafter referred to as Cited1-CreERT2 mice. R26RLacZ mice were obtained
Fig. 1. Generation and characterization of Cited1-CreERT2 mice. (A) Schematic of the targeting strategy used to create the BAC Cited1-CreERT2-IRESeGFP
transgene. Hatched lines represent regions of homology. Following BAC targeting TetR was removed through Flp mediated recombination E1—Exon 1, F—Frt sites,
I—IRES; A—AflII, N—NotI, X—XhoI. (B) Dual immunofluorescence staining of E15 mouse kidneys using anti-Cited1 (red) and anti-ECadherin (green) antibodies
demonstrates endogenous Cited1 expression in the cap mesenchyme (arrows), and the absence of Cited1 expression in all ECadherin positive epithelial structures
including renal vesicles (arrowhead) and UBs (asterisk). (C/D) Low (C) and high (D) power images of the nephrogenic zone of E18 β-Gal stained Cited1-CreERT2/
R26RLacZ kidneys following E15 maternal injection of tamoxifen. Recombination is observed within the cap mesenchyme (arrows) and early nephronic epithelia
including renal vesicles (arrowheads). No recombination is observed in UBs (asterisks). (E) β-Gal stained kidney from E18 Cited1-CreERT2/R26RLacZ embryo
whose mother was not injected with tamoxifen. (F/G) Anti-Cited1 antibody staining (F) corresponds to eGFP signal (G) within the cap mesenchyme (arrows) in mice
carrying the Cited1-CreERT2-IRESeGFP transgene. No expression observed in UBs (asterisk). (H) Merged image of panel F and panel G demonstrating overlapping
expression of Cited1 and eGFP.
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tamoxifen (Sigma T5648) was dissolved by sonication in 10% EtOH/90%
sunflower oil at a concentration of 15 mg/ml. 100 μl (1.5 mg) was injected
intraperitoneally (IP) into pregnant R26RLacZ females at times indicated. As
tamoxifen injection can compromise the ability of mice to have natural birth,
pups were delivered by cesarean section at E19.5–E20 (day of vaginal plug
appearance counted as E0.5). After pups were breathing independently they
were transferred to foster mothers who had given birth the previous day and had
begun nursing. The overall success rate of fostering was N80%.Genotyping and quantitative genomic PCR
Founders and subsequent offspring were genotyped using the following
primer sets; Cre: 5′ GGC GCG GCA ACA CCATTT TT; 3′ TCC GGG CTG
CCA CGA CCAA. Rosa26RLacZ: 5′A AAA GTC GCT CTG AGT TGT TAT;
5′B GCG AAG AGT TTG TCC TCA ACC; 3′ GGA GCG GGA GAA ATG
GAT ATG. Transgene copy number was estimated using TaqMan based real-
time PCR using genomic DNA as described (Chandler et al., 2007). Briefly, the
chloramphenicol cassette within the BAC vector was amplified using a custom
237S. Boyle et al. / Developmental Biology 313 (2008) 234–245primer set from Applied Biosystems (5′: GCA CAA GTT TTATCC GGC CTT
TAT T; 3′: GTC TTT CAT TGC CAT ACG GAA CTC; and an internal FAM-
labeled probe CCG CCT GAT GAATGC). To estimate copy number, triplicate
ΔCT values for the chloramphenicol cassette relative to a genomic DNA
control, Jun kinase, were compared to the ΔCT values of known quantities of
BAC DNA prepared to estimate copy number equivalents.
β-Gal staining
Kidneys were isolated in cold PBS and fixed in 0.2% glutaraldehyde in PBS
with 2 mM MgCl2 and 5 mM EGTA, or 4% formaldehyde in PBS for dual β-
Gal/immunoperoxidase staining. Fixation times were determined empirically
and varied from 1 h to overnight (O/N) at 4 °C according to age. Following
fixation, tissues were cryoprotected in a gradient of first 15% (4 h) and then 30%
(O/N) sucrose in PBS at 4 °C, embedded in OCT, and sectioned at 10 μm. For
staining of frozen sections, slides were thawed and equilibrated in β-Gal wash
(0.1 M Phosphate buffer pH 7.3 containing 2 mM MgCl2, 5 mM EGTA, 0.02%
NP40, 0.01% Na Deoxycholate) and stained O/N at 37 °C in β-Gal wash
containing 1 mg/ml X-Gal and 5 mM K ferro- and ferricyanate. Sections were
counterstained with eosin, dehydrated and mounted.
Antibody staining
For immunofluorescence studies kidneys were isolated and fixed for 1 h
with 4% formaldehyde in PBS at 4 °C. Following fixation, tissue was rinsed in
PBS and cryoprotected in a sucrose gradient, embedded in OCT, and sectioned
at 8 μm onto charged slides. For staining, slides were thawed, rinsed in PBS and
blocked in 10% goat serum (Vector Labs) in PBS for 1 h. Tissue was incubated
with primary antibodies in 10% goat serum in PBS O/N at 4 °C, washed 3 times
in PBS, and incubated with secondary antibodies for 1 h at R/T. After washing in
PBS, tissue was mounted with Vectashield mounting medium containing DAPI
(Vector Labs). When antibodies used for co-labeling were of the same species,
sequential sections were used. For immunoperoxidase/β-Gal studies, formalde-
hyde fixed sections were first β-Gal stained for 4 h, rinsed in PBS, then blocked
and incubated with primary antibody as described above. Tissues were
incubated with goat anti-rabbit HRP secondary antibody (Santa Cruz #SC-
2054; 1:100) for 45 min at 37 °C, developed with DAB (Sigma #D4168),
dehydrated and mounted. Antibodies used were as follows. Primary antibodies;
rabbit anti-Cited1 (Neomarkers #RB-9219; 1:250), mouse anti-ECadherin (BD
Biosciences #610181; 1:350), mouse anti-Cre (Covance #MMS106P; 1:100),
mouse anti-GFP (Molecular Probes Clone Mab3E6 #A11120), rabbit anti-β-Gal
(Cappel #55976, 1:5000), mouse anti-Na+/K+ atpase α-1 subunit (Upstate #05-
369; 1:250), rat anti-PECAM1 (BD Biosciences #553370; 1:250), hamster anti-
Podoplanin (Angiobio # 11033; 1:500), rabbit anti-WT1 (Santa Cruz #SC192;
1:100), rabbit anti-Aquaporin 1 (Chemicon # AB3065; 1:250), rabbit anti-
Aquaporin 2 (Alpha Diagnostics #AQP21-A; 1:250). Secondary antibodies;
goat anti-rabbit Rhodamine X (Jackson #111-295-144; 1:300), horse anti-mouse
Fluorescein (Vector Labs #FI-2000; 1:300), horse anti-mouse Texas Red (Vector
Labs #TI-2000; 1:300), goat anti-hamster Alexafluor 488 (Molecular Probes
#A21110; 1:300) and goat anti-Rat Alexafluor 488 (Molecular Probes #A11006;
1:300). Fluorescence images were acquired using a Nikon Elipse E800
epifluorescence microscope fitted with a SPOT RT slider 2.3.0 digital imaging
camera. Color overlays were generated using Adobe Photoshop Version 9.0.2.
Results
Generation and characterization of Cited1-CreERT2
transgenic mice
To create a fate map of the cap mesenchyme we created Ci-
ted1-CreERT2 mice using BAC transgenesis. The BAC clone we
modified for creation of the Cited1-CreERT2 transgene was
selected based on the relative position of the Cited1 locus within
its genomic sequence. We used established BAC recombination
techniques to insert a CreERT2-IRESeGFP cassette into theBAC Cited1 locus between∼190 kb of upstream and∼30 kb of
downstream genomic sequence that we can reasonably assume
contains the regulatory elements necessary to drive gene
expression analogous to endogenous protein (for review on
BAC transgenesis see; Giraldo and Montoliu, 2001; Liu et al.,
2003; Nishinakamura et al., 2001) (Fig. 1A). This cassette
encodes Cre recombinase fused to the ligand binding domain of
a modified estrogen receptor that binds the estrogen analog
tamoxifen with much higher affinity than endogenous estrogens.
This system takes advantage of ligand-dependent nuclear import
of ERT2, so that Cre translocates to the nucleus (and is thus
active) only in the presence of tamoxifen (Feil et al., 1996,
1997). In addition, the cassette includes an internal ribosomal
entry site (IRES) allowing for independent translation of eGFP,
which is used as a marker of transgene expression.
Pronuclear injection of ∼200 zygotes with the Cited1-
CreERT2 BAC transgene resulted in 29 live births, 6 of which
were determined by PCR to carry Cre recombinase (data not
shown). Four of these animals transmitted the transgene in their
germline and were evaluated for recombination potential. For
this, we crossed candidate founders with the R26RLacZ
conditional reporter (Soriano, 1999), treated pregnant females
with a single IP dose of tamoxifen at E15, and evaluated
recombination in kidneys at E18 using β-Gal staining. We chose
these time points based on the robust expression of Cited1 in the
cap mesenchyme at E15 and the abundance of MM present
during this period of kidney development (Fig. 1B; Boyle et al.,
2007). This window also allows time for LacZ expression to be
initiated in cells that have undergone recombination. Offspring
of three founders clearly exhibited recombination outside of the
Cited1 expression domain, including widespread labeling in the
UB, which we found was due to ectopic expression of the
transgene (data not shown). One line however showed LacZ
expression exclusively in the cap mesenchyme and its early
derivatives including renal vesicles and S-shaped bodies (Figs.
1C, D), and no recombination was observed in this line in the
absence of tamoxifen (Fig. 1E). To demonstrate faithful
transgene expression in the cap mesenchyme of Cited1-CreER-
T2 mice we compared expression of endogenous Cited1 protein
and eGFP at E15.5. Direct visualization of eGFP on sections
stained with anti-Cited1 antibody revealed that expression of the
Cited1-CreERT2 transgene precisely overlaps with expression of
endogenous protein (Figs. 1F–H). Staining using an anti-GFP
antibody further confirmed proper transgene expression (data
not shown). Together, these results indicate that this line of Ci-
ted1-CreERT2 mice expresses the transgene throughout the cap
mesenchyme, and that this induces relatively efficient recombi-
nation at the R26RLacZ locus following a single IP injection of
tamoxifen.
Because BACs contain large segments of genomic DNA (on
the order of 200 kb) and tend to integrate into the genome as
concatamers, stable transmission of transgene copy number
from parent to offspring can be variable as a result of linkage
disequilibrium, and is often not established until after the F1
generation (DM, personal communication). To characterize
copy number transmission in Cited1-CreERT2 mice we utilized
a genomic quantitative PCR method (Chandler et al., 2007).
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approximately five copies of the CreERT2 transgene. By
crossing this mouse to a wild type female we examined the
transmission pattern of the transgene. Analysis of the F1
generation suggested transmission of a single transgene
insertion site and showed that Cre-positive F1 animals were
estimated to carry between 1 and 5 copies of the transgene.
When F1 males carrying an estimated four copies of the trans-
gene were crossed to wild type females, all Cre-positive
progeny carried approximately four copies of CreERT2. This
four-copy transgene insertion was stably transmitted through
the F4 generation. Animals generated from this line are referred
to as Cited1-CreERT2 mice and were used for all studies to map
cap mesenchyme fate presented in this manuscript.
The cap mesenchyme gives rise to cells in all segments of the
adult nephron
To test the overall lineage potential of the cap mesenchyme,
we crossed Cited1-CreERT2 mice to the R26RLacZ line andFig. 2. The cap mesenchyme gives rise to cells in all regions of the adult kidney. Cite
with tamoxifen at E13. Lineage was assessed using β-Gal staining in 6-week-old mice
and inner medulla (papillary) region (C) show cap mesenchyme derived cells in all
some of these cell types are recognizable by morphology, including proximal tubul
(arrowheads), the medulla (E) and papilla (F) contain cap mesenchyme derived cells w
of these structures).treated pregnant females with a single IP injection of tamoxifen
at E13, when Cited1 is strongly expressed in the cap
mesenchyme (Boyle et al., 2007). By waiting until 6 weeks
of age to examine cell lineage (by which time post-natal
nephrogenesis is complete) we were able to ascertain the
definitive fate potential of Cited1 expressing cap mesenchyme
cells. β-Gal staining of adult kidneys revealed widespread
LacZ expression in a large proportion of nephrons, including
multiple cell lineages in the cortical and medullary regions
(Figs. 2A–C). Some of these lineages were evident based on
morphology and position, including cortical proximal tubules
and cells within glomeruli (Fig. 2D). Cell types were more
difficult to distinguish morphologically in the renal medulla.
Here, more distal nephronic elements and collecting ducts are
closely associated with vascular structures as they descend into
the papilla (Figs. 2B, C). In these regions, we observed LacZ
positive cells incorporated into thinner, more elongated tubular
structures (Figs. 2E, F). This morphology and position is
consistent with multiple cell types in the adult kidney including
collecting ducts, loops of Henle and vascular endothelium.d1-CreERT2 mice were crossed to R26RLacZ mice and pregnant females injected
. (A–C) Low power images of the entire kidney (A), corticomedullary region (B)
areas of the kidney. Cx—cortex, Md—medulla, Pa—papilla. (D) In the cortex,
es (arrowheads) and glomeruli (arrows). (E/F) In addition to tubular epithelium
hich have a more elongated phenotype (arrows, inset shows higher power image
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and cell-type specific markers for dual immunofluorescence.
β-Gal co-localized with Na+/K+ atpase (α1 subunit), a broadly
expressed marker of nephronic epithelia (Figs. 3A–C). In
addition, β-gal staining co-localized with podoplanin, indicating
cap mesenchyme lineage in the glomerular epithelium (Figs.
3D–F). These findings were confirmed by co-localization of β-
Gal with the podocyte specific marker WT1 on sequential
sections (Figs. 3G, G′). Aquaporin 1 (Aqp1) is expressed in
proximal tubules in the cortex and the thin limb of the loops of
Henle in the medulla. Staining of sequential sections withFig. 3. Cap mesenchyme gives rise to diverse populations of renal epithelial cells. C
examined at 6 weeks of age. (A–C) β-gal positive cells coincide with Na/K atpase e
section. (D–F) β-gal (D) and podoplanin (E) expression overlap (F) demonstrating ca
Staining of sequential sections with anti-WT1 (G, nuclear) and anti-β-Gal (G′, cyto
glomerular outline is indicated with dashed white lines. (H/H′) Staining of sequent
mesenchyme gives rise to thin limb epithelium in the papilla. (I/J) Immunoperoxidase
mesenchyme derived cells in thin limb in the papilla (I) and in proximal tubules inantibodies against Aqp1 and β-Gal revealed that thin limb
tubular epithelium in the renal papilla is derived from the cap
mesenchyme (Figs. 3H, H′). This lineage is demonstrated with
greater resolution using Aqp1 immunoperoxidase staining on
sections which have been stained for β-Gal activity (Fig. 3I).
These studies also detected LacZ positive cells co-expressing
Aqp1 in the cortex, confirming cap mesenchyme lineage in the
proximal tubular epithelium (Fig. 3J). Together, these studies
show that the cap mesenchyme gives rise to a wide variety of
epithelial cell types in the nephron including proximal, distal and
glomerular elements.ited1-CreERT2/R26RLacZ mice were injected with tamoxifen at E13 and lineage
xpression, a broad marker of nephronic epithelium. Inset shows tubule in cross
p mesenchyme lineage in the glomerular epithelial compartment (arrows). (G/G′)
plasmic) shows that the cap mesenchyme gives rise to podocytes (arrows). The
ial sections with anti-Aqp1 (H) and anti-β-Gal (H′) demonstrates that the cap
staining using anti-Aqp1 on sections which have been β-Gal stained shows cap
the cortex (J).
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epithelium or endothelial cells
Previous in vitro lineage tracing studies using explanted
nephrogenic tissue have suggested that the condensed mesench-
yme can give rise to cells within the mature collecting duct
epithelium (Qiao et al., 1995). Using the collecting duct specific
marker Aquaporin2 (Aqp2) and the β-Gal antibody on
sequential sections we asked whether the cap mesenchyme
contributes to the collecting system. Using this analysis, we sawFig. 4. Neither collecting duct epithelium or renal endothelium arises from the cap me
and lineage was examined by staining with anti-β-Galactosidase antibodies at 6 week
Aqp2 (B, B′) demonstrates that cap mesenchyme derived cells do not populate the co
distinct from, Aqp2 positive collecting ducts (arrowheads). Position of one of the coll
β-Gal staining. (C/D) Immunoperoxidase staining using anti-Aqp2 on sections which
not overlap with either cortical (I, arrowheads) or medullary collecting ducts (J, arr
endothelial cells (F) do not overlap in glomeruli (G). (H–J) Elongated cap mesenchy
endothelium (I, arrowheads) but instead run alongside their closely associated vascuno evidence for cap mesenchyme derived cells in medullary
collecting ducts (Figs. 4A/A′, B/B′). This was confirmed using
immunoperoxidase staining to detect Aqp2 on sections which
had been β-Gal stained (Figs. 4C, D), again indicating that the
cap mesenchyme does not contribute to either cortical or
medullary collecting ducts. Given the close proximity of these
epithelial elements to vascular structures within the adult kidney
we also asked whether the cap mesenchyme gave rise to
endothelial cells. For this, we looked forβ-Gal positive cells that
co-express the endothelial specific marker PECAM-1/CD31.senchyme. Cited1-CreERT2/R26RLacZ mice were injected with tamoxifen at E13
s of age. (A–B′) Staining of sequential sections with anti-β-Gal (A, A′) and anti-
llecting duct epithelium. LacZ positive cells (arrows) are closely opposed to, but
ecting ducts is indicated with dashed white lines, illustrating lack of overlap with
have been β-Gal stained shows that cap mesenchyme derived cells (arrows) do
owheads). Gl—glomeruli. (E–G) Cap derived cells (E) and PECAM1 positive
me progeny in the medulla (H, arrows) do not coincide with PECAM1 positive
lature (J).
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endothelium, in either glomeruli (Figs. 4E–G) or in the medulla
(Figs. 4H–J). It is likely that the elongated cells we saw in the
β-Gal stained renal medullas are nephronic elements (i.e. thin
limb epithelium) closely opposed to the associated vasa-recta
(Fig. 4J).
From these studies we conclude that the cap mesenchyme
does not give rise to renal endothelium or cells within the
collecting system.
Patterns of nephron formation during development
The inducible nature of the Cited1-CreERT2 transgene
makes it a useful tool to ask whether the potential of the cap
mesenchyme changes over the course of nephrogenesis. To test
this we carried out pulse-chase experiments in which we crossed
Cited1-CreERT2 mice with the R26RLacZ reporter, treated
females with a single dose of tamoxifen at various time points
during embryogenesis, and examined lineage patterns at
6 weeks of age. We observed LacZ positive cells in all parts
of the adult kidney following injection at the earliest time point,
E11, although recombination was not widespread (Fig. 5A).
However, we did observe robust recombination in the heart,
where Cited1 is also expressed (Dunwoodie et al., 1998), after
an E11 injection of tamoxifen (SB and MdC, unpublished data).
This makes it unlikely that placental delivery of tamoxifen to
the embryo is impaired at E11, and suggests that the relatively
low number of nephrons labeled by injecting at this pointFig. 5. Cap mesenchyme derived nephrons assume temporally-dependent deep and
R26RLacZ reporter mice and injected with 1.5 mg of tamoxifen at times indicated. Mic
E11 injections result in recombination in a low percentage of nephrons, but cap deriv
E13 (B) and E15 (C) results in recombination in a large proportion of nephrons,
recombination in an intermediate number of nephrons, however these structures do noreflects the low levels of Cited1 in the early condensing MM
(Boyle et al., 2007). In contrast to an E11 injection of
tamoxifen, treatment at E13 labeled a large proportion of
nephrons throughout the adult kidney (Fig. 5B). E15 injection
resulted in a similar pattern, although fewer total nephrons were
labeled (Fig. 5C). This is consistent with the morphometric
observation that many primitive nephrons arise prior to E16
(Cebrian et al., 2004). Tamoxifen treatment at later time points,
however, resulted in a distinct pattern of LacZ expression.
Following injection at E18, LacZ positive cells were observed
in the cortex and the outer medulla, but unlike the earlier
injection time points, did not reach the papilla (Fig. 5D). These
data provide in vivo evidence that nephrons arising at different
times during development assume distinct deep and superficial
positions in the adult.
The cap mesenchyme includes a self-renewing population of
epithelial progenitor cells
Studies in which we tracked the fate of cap mesenchyme
cells labeled at E13 demonstrated that a large proportion of
nephronic epithelia in the adult kidney are derived from the
relatively small number of cap cells present at this time (Fig. 2).
These findings suggest that cap mesenchyme cells not only
differentiate into nephronic epithelium, but also give rise to new
progenitor cells within the MM that develop and condense
around branching UB tips as nephrogenesis proceeds. To de-
termine whether this is the case, we first evaluated the kineticssuperficial positions in the adult kidney. Cited1-CreERT2 mice were crossed to
e were sacrificed at 6 weeks of age and lineage assessed with β-Gal staining. (A)
ed cells are found in the cortex, medulla, and papilla (arrows). (B/C) Injection at
some of which extend into the papilla (arrows). (D) E18 injection results in
t extend into the papilla (arrowheads). Cx—cortex, Md—medulla, Pa—papilla.
242 S. Boyle et al. / Developmental Biology 313 (2008) 234–245of tamoxifen-dependent activation of CreERT2 using this model
system. We did this to ensure that any labeled cells found in the
cap mesenchyme several days after tamoxifen treatment were
not the result of persistent CreERT2 nuclear translocation. To
evaluate this in Cited1-CreERT2 mice, we examined the sub-
cellular localization of Cre over a time course following
tamoxifen injection between E14.5 and E16. In uninjected mice,
antibody staining revealed that Cre was virtually exclusively
localized in the cytoplasm of cap mesenchyme cells (Figs. 6A,
A′). Some nuclear translocation of Cre was observed 8 h after
tamoxifen injection (Figs. 6B, B′), but by 24 h, Cre protein was
strongly localized to the nucleus in the majority of cap
mesenchyme cells (Figs. 6C, C′). By 96 h post-injection, Cre
protein had redistributed to the cytoplasm and is therefore no
longer active (Figs. 6D, D′).
Having established that tamoxifen-dependent activation of
the CreERT2 transgene was complete no later than 4 days
following a single IP injection of tamoxifen, we evaluated cap
mesenchyme lineage in Cited1-CreERT2/R26RLacZ mice at
E19.5 following tamoxifen treatment at E13. By this time
several generations of nephrons have emerged from the MM,
yet the nephrogenic zone remains robust due to the repetitive
nature of branching and induction during kidney development.
β-Gal staining of kidneys from these mice revealed that 6.5
days after tamoxifen injection most cap mesenchyme derived
cells are located in the outer cortex, with only a few labeled cells
in the embryonic medulla (Fig. 7A). Looking closely at the
nephrogenic region and early corticomedullary boundary, we
observed three general zones of LacZ positive cells (Fig. 7B).
The deepest region (zone 3, Fig. 7B) contained labeled cells that
have gone through the stepwise process of epithelial differ-
entiation and are extending into the medulla. These presumablyFig. 6. Kinetics of CreERT2 sub-cellular localization following tamoxifen injection.
(A′–D′) corresponding images with DAPI overlay to illustrate nuclei. Kidneys from
after tamoxifen injection (B, B′) Cre is seen in cytoplasmic (arrows) and nuclear
exclusively in nuclei (arrowheads). 96 h post-injection (D, D′) Cre has redistributedwere the first cells to differentiate from the cap following
tamoxifen injection. The intermediate zone (zone 2, Fig. 7B)
was characterized by primitive nephrons at various stages of
differentiation, such as comma- and S-shaped bodies. The
outermost zone (zone 1, Fig. 7B) included LacZ positive cells in
the early stages of differentiation, the renal vesicles and pre-
tubular aggregates. Strikingly, we also saw that a high
percentage of cap mesenchyme cells were still labeled at
E19.5 (Figs. 6B–D), demonstrating that these are progeny of
cap cells originally labeled at E13. Given the observation that
cap mesenchyme labeled at E13 gives rise to a large number of
primitive nephrons by E19.5, and that the UB has branched
extensively over this time period (accompanied by the
corresponding increase of cap mesenchyme), these findings
demonstrate that the cap mesenchyme is repopulated by an
intrinsic, self-renewing population of cells.
Discussion
In these studies, we describe the generation of Cited1-
CreERT2 BAC transgenic mice which express tamoxifen-
activated Cre recombinase in a discrete subpopulation of cells
within the condensed MM known as the cap mesenchyme.
These mice provide a unique reagent that induces efficient Cre-
dependent recombination restricted to the cap mesenchyme
following a single IP injection of tamoxifen, and incorporates a
functional IRES-eGFP marker that could be used for enrich-
ment of Cited1 positive cells in future studies. We have
exploited this transgenic system to generate the first detailed in
vivo fate map of cap mesenchyme cells over the course of
nephrogenesis. By crossing Cited1-CreERT2 BAC transgenic
mice with the R26RLacZ conditional reporter line, and activating(A–D) CreERT2 localization using anti-Cre antibody staining in E16.5 kidneys;
uninjected animals (A, A′) show cytoplasmic localization of Cre (arrows). 8 h
compartments (arrowheads). 24 h after injection (C, C′) Cre is found almost
to the cytoplasm in the cap mesenchyme (arrows). UB—ureteric bud.
Fig. 7. The cap mesenchyme gives rise to successive generations of renal progenitor cells. Pregnant Cited1-CreERT2/R26RLacZ mice were injected with tamoxifen at
E13 and lineage was examined at E19.5 using β-Gal staining. (A) Low power image of whole kidney shows cells of cap mesenchyme origin have begun to move into
distal locations (arrows). (B) Nephrogenic zone and primitive corticomedullary junction; cap derived cells are seen in the medulla (arrows, zone 3), inner nephrogenic
region (zone 2) in comma- and S-shaped bodies (black arrowheads), and outer nephrogenic region (zone 1) containing cap mesenchyme (white arrows) and renal
vesicles (white arrowheads). (C) Outer nephrogenic zone demonstrating cap mesenchyme lineage in primitive nephrons (arrowheads) and retention of labeled cells in
the cap mesenchyme (arrows). (D) High power image of the branched UB tip. Persistent labeling of cells in the cap mesenchyme at E19.5 indicates that these are
progeny of cap cells originally labeled at E13.
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mesenchyme derived cells at different stages of nephrogenesis.
Using this approach our studies confirm what was predicted
from the results of previous in vitro studies indicating that the
cap mesenchyme gives rise to a wide variety of nephronic
epithelial cell types. They also clarify conflicting in vitro data
regarding the mixed ontogeny of the collecting duct epithelium
by demonstrating definitively that the cap mesenchyme does
not contribute to collecting duct epithelium within the adult
kidney. We also demonstrate that the positioning of nephrons
within the adult kidney depends on the stage at which they
develop from the cap mesenchyme, and importantly, provide the
first substantive evidence that these cells contain a population of
self-renewing epithelial progenitor cells.
We chose to use Cited1 promoter elements to drive Cre
expression in the developing kidney given its unique and
restricted expression domain in the cap mesenchyme. Previous
studies from our laboratory have shown that Cited1 expression
increases in the condensed MM from E12.5 and persists in the
cap mesenchyme throughout nephrogenesis, but is absent in the
adult kidney (Boyle et al., 2007). Cited1 expression is distinct
from that of Six2,which is expressed strongly in theMM prior to
UB invasion and in early condensations, and extends outside of
the Cited1 expression domain to overlie UB branch points (Self
et al., 2006). This indicates that Cited1 is expressed in a
subpopulation of Six2 positive cap mesenchyme, and will beimportant for future comparison with lineage tracing studies
using other MM specific Cre lines.
Initial characterization of this transgenic line demonstrated
Cre-mediated recombination at the Rosa26RLacZ locus in
approximately 40–50% of cap mesenchyme cells 72 h after a
single injection of tamoxifen. In addition, there was widespread
β-gal expression in nephronic epithelia throughout the adult
kidney after a single IP injection at E13. As Cre-dependent
recombination is a stochastic event (Nagy, 2000), these findings
suggest that with multiple tamoxifen injections, this transgenic
line will induce highly efficient recombination in the acute
setting and will provide a powerful tool to study the effect of
gene deletions within the cap mesenchyme. Further character-
ization of this line indicated that Cre-dependent recombination
reflects the pattern of endogenous Cited1 expression over the
course of nephrogenesis (Boyle et al., 2007). For example, we
have previously shown that Cited1 expression at E11 is weak
and restricted to a few cells in the MM. Correspondingly, when
we injected Cited1-CreERT2/R26RLacZ mice at E11 and
examined cap mesenchyme lineage in the adult, we observed
a low percentage of total nephrons labeled. This was not due to
inefficient placental transfer of tamoxifen as we saw efficient
Cre-dependent recombination within the developing myocar-
dium at the same time point. In contrast, when we treated mice
with tamoxifen at E13, by which time Cited1 expression in the
cap mesenchyme is robust (Boyle et al., 2007), we saw
244 S. Boyle et al. / Developmental Biology 313 (2008) 234–245recombination in a large proportion of adult nephronic
epithelium. Furthermore, the declining percentage of labeled
epithelium in the adult following injection at E15 and E18,
respectively, is consistent with the fact that many primitive
nephrons arise prior to these time points.
These fate mapping studies provide in vivo evidence that the
cap mesenchyme gives rise to a wide variety of nephronic
epithelial cell types populating the cortex and medulla of the
adult kidney, confirming results predicted from classical tissue
recombination experiments as well as in vitro lineage tracing
studies. However, technical limitations of in vitro explant studies
do not allow for the differential labeling and fate mapping
specifically of cap mesenchyme vs. pre-tubular aggregates and
stromal mesenchyme within the MM. Our studies, therefore,
provide direct evidence that the cap mesenhcyme is the primary
source of the epithelial progenitor cells that will comprise the
mature nephron. In addition, these studies show, in vivo, that
the cap mesenchyme does not contribute to collecting duct
epithelium.
The transient nature of tamoxifen-induced activation of
CreERT2 provides an opportunity to track the fate and spatial
distribution of cells derived from the cap mesenchyme at
different stages of nephrogenesis. This enabled us to address
one of the key unanswered questions in this field: Is the cap
mesenchyme repopulated intrinsically over the course of
nephrogenesis or through the continual migration of extrinsic
cells? Our studies show that a high proportion of cap
mesenchyme cells still express LacZ 6.5 days after a single IP
injection of tamoxifen. It is unlikely this is due to persistent
tamoxifen-induced activation of CreERT2 as we demonstrated
that tamoxifen-induced nuclear localization of CreERT2 was
maximal 24 h following injection with no detectable nuclear
Cre after 96 h. Furthermore, previous studies have characterized
the kinetics of Cre activation in more detail, indicating that most
of the Cre returns to the cytoplasm 48 h after a single tamoxifen
injection (Hayashi and McMahon, 2002; Nakamura et al.,
2006). On this basis, if exogenous cells were being recruited to
repopulate this niche, we would expect that a high percentage of
cap mesenchyme cells present at the time of injection would not
be labeled a week later, as the originally tagged cells would
have been depleted by induction and differentiation and
progressively replaced by unlabeled cells. These findings
provide the first strong in vivo evidence that an intrinsic, self-
renewing population of progenitor cells reconstitutes the cap
mesenchyme over the course of nephrogenesis.
By tracking the fate of nephronic epithelium labeled early vs.
late in nephrogenesis, our studies also provide in vivo evidence
that deep nephrons extending into the renal papilla arise only
during the early phase of nephrogenesis and that nephrons
arising at later stages of development are restricted to the cortex
and outer medulla. As deep and superficial nephrons contain all
of the same cell types, this does not represent a shift in cell fate
per se, but provides in vivo evidence that the positioning of
nephrons within the adult kidney is temporally regulated. There
are several possible explanations for this phenomenon. It is
possible that nephrons arising later are physically ‘blocked’
from extending into the medulla by early nephrons that havealready migrated into the papilla as corticomedullary patterning
begins at ∼E16 (Cebrian et al., 2004). Given the fact that
formation of the renal pelvis is poorly understood, a more
intriguing explanation would be the differential expression of an
unidentified chemotactic factor that directs migration of distal
elements into the papilla. Perhaps this factor is down-regulated
once an appropriate number of nephrons have arrived, leaving
tubules arising later to occupy superficial positions. In any case,
the temporally dependent organization of nephronic elements
observed in our studies supports what has been predicted by
classical anatomical studies of the adult kidney indicating that
nephrons are organized into deep and superficial structures
(Kriz and Koepsell, 1974).
In summary, we describe the generation and characterization
of Cited1-CreERT2 BAC transgenic mice, which express
tamoxifen-regulated Cre recombinase exclusively in the cap
mesenchyme within the developing kidney. By crossing these
mice with a conditional reporter line, we have evaluated the fate
of cap mesenchyme cells over the course nephrogenesis. These
studies confirm the expected findings that cap mesenchyme
gives rise to diverse nephronic epithelia in the adult kidney, and
provide the first evidence that the cap mesenchyme contains a
population of self-renewing epithelial progenitor cells.
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